医学
肺动脉高压
结缔组织病
结缔组织
疾病
病理
重症监护医学
内科学
自身免疫性疾病
标识
DOI:10.1016/j.rdc.2024.03.005
摘要
Pulmonary hypertension (PH), a syndrome characterized by elevated pulmonary pressures, commonly complicates connective tissue disease (CTD) and is associated with increased morbidity and mortality. The incidence of PH varies widely between CTDs; patients with systemic sclerosis are most likely to develop PH. Several different types of PH can present in CTD, including PH related to left heart disease and respiratory disease. Importantly, CTD patients are at risk for developing pulmonary arterial hypertension, a rare form of PH that is associated with high morbidity and mortality. Future therapies targeting pulmonary vascular remodeling may improve outcomes for patients with this devastating disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI